November 21, 2011 InteRNA Technologies announces establishment of Supervisory Board November 8, 2011 ORCA Therapeutics receives up to € 5 Million Innovation Credit from Dutch Government

18-21 June 2012
2012 BIO International Convention
Boston, USA

Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development.

In its commitment to create and build biomedical companies in the field of oncology, Aglaia does not only provide the financial means but also takes an active role in strategic and operational processes.

Aglaia Biomedical Ventures B.V. currently has two investment funds under management: Aglaia Oncology Fund B.V.and Aglaia Oncology Seed Fund B.V.